Control of endothelial barrier function by regulating vascular endothelial-cadherin

Current Opinion in Hematology

Volumn 17, Issue 3, 2010, Pages 230-236

  Vestweber, Dietmar ^a   Broermann, Andre ^a   Schulte, Dörte ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

Author keywords

Endothelial cell contacts; Leukocyte extravasation; Vascular endothelial cadherin; Vascular permeability

Indexed keywords

CADHERIN; CATENIN; CELL ADHESION MOLECULE; JUNCTIONAL ADHESION MOLECULE A;

BLOOD VESSEL PERMEABILITY; CELL CONTACT; CYTOSKELETON; INFLAMMATION; PRIORITY JOURNAL; REVIEW; SHOCK; VASCULAR ENDOTHELIUM;

ANIMALS; CADHERINS; CELL ADHESION; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM, VASCULAR; HUMANS; LEUKOCYTES; SIGNAL TRANSDUCTION;

EID: 77951495204     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328338664b     Document Type: Review

References (60)

1. Ley K, LaudannaC, Cybulsky MI, et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7:678-689.
2. Woodfin A, Voisin MB, Nourshargh S. Recent developments and complexities in neutrophil transmigration. Curr Opin Hematol 2010; 17:9-17.
3. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86:279-367.
4. Carman CV, Springer TA. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol 2004; 167:377-388.
5. Carman CV, Springer TA. Trans-cellular migration: cell-cell contacts get intimate. Curr Opin Cell Biol 2008; 20:1-8.
6. Millan JL, Hewlett L, Glyn M, et al. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola-and F-actin-rich domains. Nat Cell Biol 2006; 8:113-123.
7. Nieminen M, Henttinen T, Merinen M, et al. Vimentin function in lymphocyte adhesion and transcellular migration. Nat Cell Biol 2006; 8:156-162.
8. Keuschnigg J, Henttinen T, Auvinen K, et al. The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood 2009; 114:478-484.
9. Marmon S, Hinchey J, Oh P, et al. Caveolin-1 expression determines the route of neutrophil extravasation through skin microvasculature. Am J Pathol 2009; 174:684-692.
10. Vestweber D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 2007; 218:178-196.
11. Dejana E, Orsenigo F, Molendini C, et al. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res 2009; 335:17-25.
12. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008; 121:2115-2122.
13. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008; 28:223-232.
14. Lampugnani MG, Corada M, Caveda L, et al. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, b-catenin, and a-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol 1995; 129:203-217.
15. Yamada S, Pokutta S, Drees F, et al. Deconstructing the cadherin-catenin-actin complex. Cell 2005; 123:889-901.
16. Xiao K, Garner J, Buckley KM, et al. p120-Catenin regulates clathrin-depen-dent endocytosis of VE-cadherin. Mol Biol Cell 2005; 16:5141-5151.
17. van Nieuw Amerongen GP, van Hinsbergh VW. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol 2002; 39:257-272.
18. Fukuhara S, Sakurai A, Sano H, et al. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 2005; 25:136-146.
19. Kooistra MR, Corada M, Dejana E, et al. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 2005; 579:4966-4972.
20. Sehrawat S, CullereX, PatelS, et al. Role of Epac1,an exchange factor for rap GTPases, in endothelial microtubule dynamics and barrier function. Mol Biol Cell 2008; 19:1261-1270.
21. Bach TL, Barsigian C, Yaen CH, et al. Endothelial cell VE-cadherin functions as a receptor for the beta15-42 sequence of fibrin. J Biol Chem 1998; 273:30719-30728. (Pubitemid 28545554)
22. Yakovlev S, Medved L. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: localization of the fibrin-binding site within the third extracellular VE-cadherin domain. Biochemistry 2009; 48:5171-5179.
23. Groger M, Pasteiner W, Ignatyev GM, et al. Peptide Bbeta(15-42) preserves endothelial barrier function in shock. PLoS One 2009; 4:e5391.
24. Heupel WM, Efthymiadis A, Schlegel N, et al. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo. J Cell Sci 2009; 122:1616-1625.
25. Saharinen P, Eklund L, Miettinen J, et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 2008; 10:527-537.
26. Fukuhara S, Sako K, Minami T, et al. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 2008; 10:513-526.
27. Nawroth R, Poell G, Ranft A, et al. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 2002; 21:4885-4895.
28. Nottebaum AF, Cagna G, Winderlich M, et al. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J Exp Med 2008; 205:2929-2945.
29. Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 2008; 14:25-36.
30. Murakami M, Nguyen LT, Zhuang ZW, et al. The FGF system has a key role in regulating vascular integrity. J Clin Invest 2008; 118:3355-3366.
31. McLachlan RW, Yap AS. Not so simple: the complexity of phosphotyrosine signaling at cadherin adhesive contacts. J Mol Med 2007; 85:545-554.
32. Tominaga J, Fukunaga Y, Abelardo E. Defining the function of beta-catenin tyrosine phosphorylation in cadherin-mediated cell-cell adhesion. Genes Cells 2008; 13:67-77.
33. Seebach J, Mä dler H-J, Wojciak-Stothard B, et al. Tyrosine phosphorylation and the small GTPase rac cross-talk in regulation of endothelial barrier function. Thromb Haemost 2005; 94:620-629.
34. Adam AP, Sharenko AL, Pumiglia K, et al. SRC-induced tyrosine phosphor-ylation of VE-cadherin is not sufficient to decrease barrier function of en-dothelial monolayers. J Biol Chem 2010 [Epub ahead of print].
35. Allingham MJ, van Buul JD, Burridge K. ICAM-1-mediated, Src-and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J Immunol 2007; 179:4053-4064.
36. Turowski P, Martinelli R, Crawford R, et al. Phosphorylation of vascular endo-thelial cadherin controls lymphocyte emigration. J Cell Sci 2008; 121:29-37.
37. Potter MD, Barbero S, Cheresh DA. Tyrosine phosphorylation of VE-cadherin prevents binding of p120-and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 2005; 280:31906-31912.
38. Monaghan-Benson E, Burridge K. The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 2009; 284:25602-25611.
39. Murakami T, Felinski EA, Antonetti DA. Occludin phosphorylation and ubiqui-tination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem 2009; 284:21036-21046.
40. Wallez Y, Cand F, Cruzalegui F, et al. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 2007; 26:1067-1077.
41. Baumeister U, Funke R, Ebnet K, et al. Association of Csk to VE-cadherin and inhibition of cell proliferation. EMBO J 2005; 24:1686-1695.
42. Ha CH, Bennett AM, Jin ZG. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor. J Biol Chem 2008; 283:7261-7720.
43. Martinelli R, Gegg M, Longbottom R, et al. ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration. Mol Biol Cell 2009; 20:995-1005.
44. van Buul JD KE, Hordijk PL. Endothelial signaling by Ig-like cell adhesion molecules. Arterioscler Thromb Vasc Biol 2007; 27:1870-1876.
45. Angelini DJ, Hyun S-W, Grigoryev DN, et al. TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol 2006; 291:L1232-L1245.
46. Gong P, Angelini DJ, Yang S, et al. TLR4 signaling is coupled to SRC family kinase activation, tyrosine phosphorylation of zonula adherens proteins, and opening of the paracellular pathway in human lung microvascular endothelia. J Biol Chem 2008; 283:13437-13449.
47. Chiasson CM, Wittich KB, Vincent PA, et al. p120-catenin inhibits VE-cadherin internalization through a Rho-independent mechanism. Mol Biol Cell 2009; 20:1970-1980.
48. Alcaide P, Newton G, Auerbach S, et al. p120-catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylation. Blood 2008; 112:2770-2779.
49. Glading A, Han J, Stockton RA, et al. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 2007; 179:247-254.
50. Kleaveland B, Zheng X, Liu JJ, et al. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat Med 2009; 15:169-176.
51. Whitehead KJ, Chan AC, Navankasattusas S, et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via RhoGTPases. Nat Med 2009; 15:177-184.
52. Gore AV, Lampugnani MG, Dye L, et al. Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke. Dis Model Mech 2008; 1:275-281.
53. Heyraud S, Jaquinod M, Durmort C, et al. Contribution of annexin 2 to the architecture of mature endothelial adherens junctions. Mol Cell Biol 2008; 28:1657-1668.
54. Nakamura Y, Patrushev N, Inomata H, et al. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. Circ Res 2008; 102:1182-1191.
55. Sui XF, Kiser TD, Hyun SW, et al. Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular en-dothelia. Am J Pathol 2005; 166:1247-1258.
56. Baumer S, Keller L, Holtmann A, et al. Vascular endothelial cell specific phospho-tyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 2006; 107:4754-4762.
57. Winderlich M, Keller L, Cagna G, et al. VE-PTP controls blood vessel development by balancing Tie-2 activity. J Cell Biol 2009; 185:657-671.
58. Mellberg S, Dimberg A, Bahram F, et al. Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis. FASEB J 2009; 23:1490-1502.
59. Abe K, Takeichi M. EPLIN mediates linkage of the cadherin catenin complex to F-actin and stabilizes the circumferential actin belt. Proc Natl Acad Sci USA 2008; 105:13-19.
60. Noda K, Zhang J, FukuharaS, et al. Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through alpha-and beta-cateninsin cyclic AMP-Epac-Rap1 signal-activated endothelial cells. Mol Biol Cell 2010; 21:584-596.